Jay Smith, Head of Product | TransPerfect

Jay is responsible for managing the creation and design of product features and new capabilities for Trial Interactive. Jay brings over 25 years of product management, consulting, and engineering experience across verticals such as life sciences, enterprise software, healthcare, government, entertainment and manufacturing.

John Doyle, Group Vice President, Health Sciences | Exponent

Dr. Doyle leads Health Sciences at Exponent, applying deep interdisciplinary expertise to evaluate a broad range of environmental, occupational, medical, and public health issues that face the world. Dr. Doyle is an epidemiologist and health services researcher who specializes in studying the risks, benefits, and value of healthcare interventions with a special concentration in oncology. Prior to his role at Exponent, John led the Global Healthcare Innovation Center at Pfizer, focused on optimizing equitable and affordable access to Pfizer’s medicine and vaccines. Dr. Doyle also serves on the faculty at the Columbia University Mailman School of Public Health since 2005.

Jen Horonjeff, Founder & CEO | Savvy Cooperative

Jen Horonjeff, PhD, is the founder and CEO of Savvy Cooperative, a patient co-op that facilitates patient and professional collaboration in healthcare innovations. Jen is a passionate patient advocate, having been diagnosed with several chronic autoimmune diseases as an infant. Prior to founding Savvy Cooperative, she earned her PhD in Environmental Medicine at New York University and went on to become a healthcare researcher, industry consultant and FDA advisor. Jen continues to serve as a patient-centered outcomes researcher at Columbia University Medical Center and utilizes her unique perspective to champion patient engagement and co-creation in research and industry around the globe. She firmly believes that we can create more meaningful solutions for patients–and do so faster–when we work together.

Joseph Kim, Chief Strategy Officer | ProofPilot

Joseph Kim brings over 23 years of pharmaceutical expertise to ProofPilot, most recently in a senior leadership role as Senior Advisor in Lilly’s Digital Health Office. He brings a wide array of pharmaceutical research industry knowledge and utilizes a unique approach that integrates his experiences working for other Sponsors such as Shire and Merck, in addition to CROs and technology vendors. He has a robust combination of experience across all phases of clinical research, and a well-known history of innovation in the industry, recognized as one of the “Top 100 individuals on the 2015 MedicineMakers Power List,” and “20 Innovators Changing the Face of the Clinical Trials Industry” by CenterWatch. He holds a BS in Molecular Biology from Lehigh University and an MBA from Villanova.

Josh Rose, Vice President, Decentralized Clinical Trials, Site Solutions and Strategy | CVS Health Clinical Trial Services

Josh Rose, Vice President, CVS Health Clinical Trial Services (CTS), is a clinical research industry veteran with more than 20 years of experience. He leads the CTS clinical trial delivery business providing patient-first research within designated HealthHUB locations, the home and virtually. Josh is also responsible for CTS strategy and partnerships. Prior to joining CVS Health, Josh was Vice President and Global Head of Strategy for the Research and Development Solutions Business at IQVIA, while also launching and leading its decentralized clinical trial (DCT) and home research nursing service businesses. Josh has an MBA from Duke University and a Bachelor of Science in chemical engineering from the University of Illinois. He lives in Chapel Hill, NC.

Jen Horonjeff, Founder & CEO | Savvy Cooperative

Jen Horonjeff, PhD, is the founder and CEO of Savvy Cooperative, a patient co-op that facilitates patient and professional collaboration in healthcare innovations. Jen is a passionate patient advocate, having been diagnosed with several chronic autoimmune diseases as an infant. Prior to founding Savvy Cooperative, she earned her PhD in Environmental Medicine at New York University and went on to become a healthcare researcher, industry consultant and FDA advisor. Jen continues to serve as a patient-centered outcomes researcher at Columbia University Medical Center and utilizes her unique perspective to champion patient engagement and co-creation in research and industry around the globe. She firmly believes that we can create more meaningful solutions for patients–and do so faster–when we work together.

Josh Rose, Vice President, Decentralized Clinical Trials, Site Solutions and Strategy | CVS Health Clinical Trial Services

Josh Rose, Vice President, CVS Health Clinical Trial Services (CTS), is a clinical research industry veteran with more than 20 years of experience. He leads the CTS clinical trial delivery business providing patient-first research within designated HealthHUB locations, the home and virtually. Josh is also responsible for CTS strategy and partnerships. Prior to joining CVS Health, Josh was Vice President and Global Head of Strategy for the Research and Development Solutions Business at IQVIA, while also launching and leading its decentralized clinical trial (DCT) and home research nursing service businesses. Josh has an MBA from Duke University and a Bachelor of Science in chemical engineering from the University of Illinois. He lives in Chapel Hill, NC.

Stefanie Kuhner, Global Head of Clinical Technology, Innovation, & Patient Recruitment – R&D Strategic Sourcing & Procurement | Bristol Myers Squibb

Stefanie Kuhner has more than 20 years of experience working in Clinical Technology, Innovation and Patient Recruitment & Engagement. She currently is the Global Head of Clinical Technology, Innovation & Patient Recruitment at Bristol Myers Squibb in R&D Procurement’s Business Partnering & Strategy (BP&S) organization. Prior to joining BMS, Stefanie worked in Medication Compliance & Adherence & Digital Biomarkers building and leading AiCure’s commercial organization. She spent 14 years in Patient Recruitment & Engagement with Acurian (now AES) before joining the AiCure team and started her career at TransPerfect Translations.

Joseph Kim, Chief Strategy Officer | ProofPilot

Joseph Kim brings over 23 years of pharmaceutical expertise to ProofPilot, most recently in a senior leadership role as Senior Advisor in Lilly’s Digital Health Office. He brings a wide array of pharmaceutical research industry knowledge and utilizes a unique approach that integrates his experiences working for other Sponsors such as Shire and Merck, in addition to CROs and technology vendors. He has a robust combination of experience across all phases of clinical research, and a well-known history of innovation in the industry, recognized as one of the “Top 100 individuals on the 2015 MedicineMakers Power List,” and “20 Innovators Changing the Face of the Clinical Trials Industry” by CenterWatch. He holds a BS in Molecular Biology from Lehigh University and an MBA from Villanova.

Michael Smyth, Division President | TransPerfect

Michael Smyth is the Division President of TransPerfect Life Sciences, including the Trial Interactive platform and its solutions. Smyth has over 20 years of experience working in the pharmaceutical clinical development industry in a multitude of positions.

Penelope Manasco M.D., CEO | MANA RBM

From basic research in the Nobel Prize award winning Andrew Schally labs in New Orleans and at the NIH, to serving as Principal Investigator for the earliest treatment of children with precocious puberty with LHRH analogs, Dr. Manasco personifies a physician scientist. Dr. Manasco served in roles of increasing responsibility in the Pharmaceutical industry. As a Vice President at Glaxo Welcome (now GSK), she led clinical development and post marketing efforts in CNS research and led the international program integrating clinical genetics and pharmacogenetics into basic and clinical research across the globe for GSK. Following a successful career at Big Pharma, Dr. Manasco has spent the last 20 years focusing on enhancing the efficiency of clinical research in executive roles at two clinical trials technology companies and as founder and CEO of MANA RBM. Dr. Manasco was named one of the PharmaVoice 100 for 2022 honorees, and currently focuses on improving clinical trial management, efficiency, and oversight using scientific methods and MANA RBM’s innovative, patent-pending software, REACHER UNIFIER. REACHER UNIFIER delivers data unification and automated data analytics across all clinical trial data across systems without requiring the traditional data conversion other systems demand, saving time and money for Sponsors and CROs. This approach ushers in a new era of automated monitoring and data exploration that will transform the industry.

Scott Dixon, Chief Commercial Officer | ObvioHealth

During his 25+ year career, Scott Dixon has integrated commercial and operational planning for life science, pharmaceutical, and healthcare software companies, including ERT, Oracle, Phase Forward, WebMD and Parexel. Most recently, he served as Chief Revenue Officer at Flywheel.io prior to joining ObvioHealth. His experience overseeing clinical development processes, as well as direct-to-patient technology, has resulted in successful breakthrough offerings for startups and Fortune 100 companies.

Craig Lipset, Co-Chair | Decentralized Trials & Research Alliance

Craig Lipset is an advisor, educator, advocate and innovator focused on novel solutions for clinical trials and medicine development. He is the founder of Clinical Innovation Partners, providing advisory and board leadership with pharma, tech and investors. Craig is Co-Chair for the Decentralized Trials & Research Alliance, Vice Chair of the MedStar Health Research Institute, and Vice President of the Foundation for Sarcoidosis. He is Adjunct Assistant Professor in Health Informatics at Rutgers University. Craig was previously the Head of Clinical Innovation and Venture Partner at Pfizer, and on the founding management teams for two successful startup ventures.

Joseph Kim, Chief Strategy Officer | ProofPilot

Joseph Kim brings over 23 years of pharmaceutical expertise to ProofPilot, most recently in a senior leadership role as Senior Advisor in Lilly’s Digital Health Office. He brings a wide array of pharmaceutical research industry knowledge and utilizes a unique approach that integrates his experiences working for other Sponsors such as Shire and Merck, in addition to CROs and technology vendors. He has a robust combination of experience across all phases of clinical research, and a well-known history of innovation in the industry, recognized as one of the “Top 100 individuals on the 2015 MedicineMakers Power List,” and “20 Innovators Changing the Face of the Clinical Trials Industry” by CenterWatch. He holds a BS in Molecular Biology from Lehigh University and an MBA from Villanova.

Craig Lipset, Co-Chair | Decentralized Trials & Research Alliance

Craig Lipset is an advisor, educator, advocate and innovator focused on novel solutions for clinical trials and medicine development. He is the founder of Clinical Innovation Partners, providing advisory and board leadership with pharma, tech and investors. Craig is Co-Chair for the Decentralized Trials & Research Alliance, Vice Chair of the MedStar Health Research Institute, and Vice President of the Foundation for Sarcoidosis. He is Adjunct Assistant Professor in Health Informatics at Rutgers University. Craig was previously the Head of Clinical Innovation and Venture Partner at Pfizer, and on the founding management teams for two successful startup ventures.

Josh Rose, Vice President, Decentralized Clinical Trials, Site Solutions and Strategy | CVS Health Clinical Trial Services

Josh Rose, Vice President, CVS Health Clinical Trial Services (CTS), is a clinical research industry veteran with more than 20 years of experience. He leads the CTS clinical trial delivery business providing patient-first research within designated HealthHUB locations, the home and virtually. Josh is also responsible for CTS strategy and partnerships. Prior to joining CVS Health, Josh was Vice President and Global Head of Strategy for the Research and Development Solutions Business at IQVIA, while also launching and leading its decentralized clinical trial (DCT) and home research nursing service businesses. Josh has an MBA from Duke University and a Bachelor of Science in chemical engineering from the University of Illinois. He lives in Chapel Hill, NC.

Jen Horonjeff, Founder & CEO | Savvy Cooperative

Jen Horonjeff, PhD, is the founder and CEO of Savvy Cooperative, a patient co-op that facilitates patient and professional collaboration in healthcare innovations. Jen is a passionate patient advocate, having been diagnosed with several chronic autoimmune diseases as an infant. Prior to founding Savvy Cooperative, she earned her PhD in Environmental Medicine at New York University and went on to become a healthcare researcher, industry consultant and FDA advisor. Jen continues to serve as a patient-centered outcomes researcher at Columbia University Medical Center and utilizes her unique perspective to champion patient engagement and co-creation in research and industry around the globe. She firmly believes that we can create more meaningful solutions for patients–and do so faster–when we work together.

Joseph Kim, Chief Strategy Officer | ProofPilot

Joseph Kim brings over 23 years of pharmaceutical expertise to ProofPilot, most recently in a senior leadership role as Senior Advisor in Lilly’s Digital Health Office. He brings a wide array of pharmaceutical research industry knowledge and utilizes a unique approach that integrates his experiences working for other Sponsors such as Shire and Merck, in addition to CROs and technology vendors. He has a robust combination of experience across all phases of clinical research, and a well-known history of innovation in the industry, recognized as one of the “Top 100 individuals on the 2015 MedicineMakers Power List,” and “20 Innovators Changing the Face of the Clinical Trials Industry” by CenterWatch. He holds a BS in Molecular Biology from Lehigh University and an MBA from Villanova.

Stefanie Kuhner, Global Head of Clinical Technology, Innovation, & Patient Recruitment – R&D Strategic Sourcing & Procurement | Bristol Myers Squibb

Stefanie Kuhner has more than 20 years of experience working in Clinical Technology, Innovation and Patient Recruitment & Engagement. She currently is the Global Head of Clinical Technology, Innovation & Patient Recruitment at Bristol Myers Squibb in R&D Procurement’s Business Partnering & Strategy (BP&S) organization. Prior to joining BMS, Stefanie worked in Medication Compliance & Adherence & Digital Biomarkers building and leading AiCure’s commercial organization. She spent 14 years in Patient Recruitment & Engagement with Acurian (now AES) before joining the AiCure team and started her career at TransPerfect Translations.